Charlene Stern
About Charlene Stern
Charlene Stern Executive Vice President and General Counsel
Charlene Stern is currently serving as the Executive Vice President and General Counsel at Editas Medicine. In her role, she oversees and manages all legal matters related to the company. This includes corporate governance, securities compliance and SEC reporting, partnering and licensing transactions, financings, and intellectual property strategy. Additionally, Charlene Stern serves as Editas Medicine's Corporate Secretary.
Charlene Stern Education and Qualifications
Charlene Stern holds an impressive academic background. She earned her J.D. from Suffolk University Law School. Additionally, she has a Ph.D. in cell and molecular biology from Yale University and an A.B. in biochemistry from Mount Holyoke College. Her solid educational foundation has been integral in shaping her career and expertise in the legal and scientific domains.
Charlene Stern Editas Medicine Launch Team
Charlene Stern was a key part of the team that launched Editas Medicine in 2013. Her involvement in the launch of the company highlights her strategic role in building and shaping the legal framework of the organization. This experience has further solidified her position and impact within the company.
Charlene Stern Career Background
Before joining Editas Medicine, Charlene Stern served as senior patent counsel at AVEO Oncology, where she was responsible for developing and executing the company's intellectual property strategy. She also worked as a senior attorney at Goodwin LLP's Boston office and served as a patent agent at Foley Hoag LLP. Earlier in her career, Charlene Stern was an American Cancer Society post-doctoral fellow at Dana-Farber Cancer Institute, which provided her with significant research and scientific insights.